Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Schering-Plough Expands In China

August 18, 2008 | A version of this story appeared in Volume 86, Issue 33

Schering-Plough has established a wholly owned Chinese subsidiary, Shanghai Schering-Plough Pharmaceutical, by buying out its former joint-venture partners in China. In 1994, Schering-Plough partnered with Shanghai Pharmaceutical Industry Co. and Shanghai Pharmaceutical Group to manufacture and sell allergy and skin-care products. According to Schering-Plough CEO Fred Hassan, the buyout is “part of Schering-Plough’s long-term global geographic expansion strategy.” The company intends to further expand its pharmaceutical business in China.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.